By performing principal component analysis on the AUC values, we discovered HSP90 inhibitors as one of the most effective and tumor-suppressing drug categories, grouping them alongside HDAC and CDK9 inhibitors (Figure 1D). Here, CDK9 is linked to neoplasm.